-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A study led by the University of Birmingham showed that if a patient has a history of periodontal disease (gum), the risk of diseases including mental illness and heart disease will increase
Experts conducted the first study of the GP records of 64,379 patients, all of whom have a documented history of periodontal disease, including gingivitis and periodontitis (periodontitis refers to gum disease that may be Will cause tooth loss)
Researchers checked the data to determine how many patients with or without periodontal disease would develop cardiovascular disease (such as heart failure, stroke, vascular dementia), cardiometabolic disorders (such as high blood pressure, type 2 diabetes) The average follow-up time for autoimmune diseases (such as arthritis, type 1 diabetes, psoriasis), and mental illness (such as depression, anxiety, and severe mental illness) is about three years
From the study published today in the journal BMJ Open, the research team found that patients with a history of periodontal disease at the beginning of the study are more likely to continue the study and be diagnosed with these additional diseases in an average of three years One, compared with the cohort without periodontal disease at the beginning of the study
Dr.
Dr.
Professor Krish Nelandara Kumar of the Institute of Applied Health at the University of Birmingham, co-senior author of the study, said: “An important implication of our findings is that effective communication is required between dental and other healthcare professionals.
Dr.
The research was partly funded by the Versus Arthritis Musculoskeletal Aging Research Center at the University of Birmingham, and was supported by the Birmingham Biomedical Research Center of the National Institute of Health Research (NIHR)
Caroline Aylott, head of research at Versus Arthritis, said: “Some of the biggest challenges of arthritis, especially autoimmune diseases, such as rheumatoid arthritis (RA), which affect 400,000 people in the UK, can know who is more likely to get joints.
The project was carried out in collaboration with Oxford University, Birmingham Dental Hospital, University of Warwick, Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastle University, Thunderville and West Birmingham NHS Trust